BioSpring is a leading industry expert in oligonucleotide science and technology, delivering products at all production scales that meet the highest quality standards for therapeutic and diagnostic applications spanning the complete lifecycle from discovery to commercial use. We are a privately owned company with a strong team of over 400 employees working to progress the potential of oligonucleotides, driven by innovation. Headquartered in the center of Europe, in Frankfurt, Germany, we are an international company with a subsidiary in the United States and a local presence in Japan. Our global clients can rely on our precision and strict cGMP compliance – guided by our expertise, passion for innovation and more than 25 years of experience. Our aim is a highly collaborative partnership to unleash the full potential of our clients’ technology – making great strides and breakthroughs possible. We are driven by our desire for a healthier world. The knowledge that there are patients who currently have no hope of curing their disease motivates us every day to make significant progress in this cutting-edge field. We produce APIs based on oligonucleotides to give these patients new hope. Privacy notice: https://www.biospring.de/datenschutz-socialmedia/